Among European patients with CF, 87.2% were heterozygous or homozygous for a class II mutation, which determines CFTR misfolding and premature degradation, and, in almost all cases, this was F508del, thus, representing the most common CFTR mutation [5]. This evidence concerns the gene CFTR and cystic fibrosis.